Herold, David et al., Ann. Clin. Lab. Sci., 13(6), 482-488 (1983).
Yue, D.K. et al., Diabetes, 31(8), 701-705 (1982).
Sigma warrants that its products conform to the information contained in this and
Herold, David et al., Ann. Clin. Lab. Sci., 13(6), 482-488 (1983).
Yue, D.K. et al., Diabetes, 31(8), 701-705 (1982).
Sigma warrants that its products conform to the information contained in this and
Herold, David et al., Ann. Clin. Lab. Sci., 13(6), 482-488 (1983).
Yue, D.K. et al., Diabetes, 31(8), 701-705 (1982).
Sigma warrants that its products conform to the information contained in this and
).
7. Thullier, P., and Sesardic, D., "Neutralization
Tests", in Antibody Engineering, Volume 1 (2nd
ed.; R. Konterman and S. Dübel, eds.). Springer-
Verlag (Berlin/Heidelberg), pp. 705-722 (2001
Application of Scepter™ Cell Counter: Cell counting (HEK293 cells)
7
Scepter Publications
(2011-present) Updated on May 31, 2013
Bardet–Biedl syndrome highlights the major role of the primary
Muhammad Munir Chaudry, Ph.D.
President
This certificate is valid until July 31, 2023 and subject to renewal at that time.
Page 7 of 99
Product Name Product Code Halal-ID Product Certificate #
Muhammad Munir Chaudry, Ph.D.
President
This certificate is valid until July 31, 2024 and subject to renewal at that time.
Page 7 of 99
Product Name Product Code Halal-ID Product Certificate #
Chemical Company, Rockford, 198
2. G. Barany, et al. (1987) Int. J. Peptide Protein Res., 30, 705.
3. G. Fields & R.L. Noble (1990) Int. J. Peptide Protein Res., 35, 161.
E. Atherton & R.C. Sheppard
PA512 510 g 0,01 g Ø 180 mm 500 g, F1 80251571 545
PA512C 510 g 0,01 g Ø 180 mm 500 g, F1 80251576 705
PA512CM 510 g 0,01 g 0,1 g Ø 180 mm 500 g, F1 80251580 820
PA2102 2100
Role of RNA methyltransferases in
tissue renewal and pathology. Curr Opin Cell Biol. 31:107.
PMID:25014650
7. Bogdanovic, O et al. (2009) DNA methylation and methyl-
CpG binding proteins: developmental
B1684 90427 BMF P NP_001003940.1 y y n/d
75 Bmf, C-Terminal B1559 90427 BMF P NP_001003940.1 y y n/d
705 Tal T1075 90678 LRSAM1 P NP_001005373.1 y y y
706 Tal T1200 90678 LRSAM1 P NP_001005373.1 y y y
669
B1684 90427 BMF P NP_001003940.1 y y n/d
75 Bmf, C-Terminal B1559 90427 BMF P NP_001003940.1 y y n/d
705 Tal T1075 90678 LRSAM1 P NP_001005373.1 y y y
706 Tal T1200 90678 LRSAM1 P NP_001005373.1 y y y
669
B1684 90427 BMF P NP_001003940.1 y y n/d
75 Bmf, C-Terminal B1559 90427 BMF P NP_001003940.1 y y n/d
705 Tal T1075 90678 LRSAM1 P NP_001005373.1 y y y
706 Tal T1200 90678 LRSAM1 P NP_001005373.1 y y y
669
S9067 M y y y
702 Syntaxin 8 S8945 P n/d n/d y
703 α-Synuclein S3062 P y n/d y
704 Negative Control NA
705 Tal T1075 P y y y
706 Tal T1200 P y y y
707 TAP T1076 M y n/d n/d
708 Tau
703 α-Synuclein S3062 29219, 6622 SNCA,Snca NP_062042.1,NP_009292.1 P y n/d y
704 Negative Control
705 Tal T1075 90678, 227738 Lrsam1,LRSAM1 NP_612370.3,NP_955006.1 P y y y
706 Tal T1200 90678, 227738 Lrsam1
α-Synuclein S3062 29219, 6622 SNCA,Snca NP_062042.1,NP_009292.1 P y n/d y
704 Negative Control NA
705 Tal T1075 90678, 227738 Lrsam1,LRSAM1 NP_612370.3,NP_955006.1 P y y y
706 Tal T1200 90678, 227738 Lrsam1